
Results
25
Most Popular Stocks on the market
25 companies
Celon Pharma
Market Cap: zł1.1b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.
CLN
zł20.80
7D
2.2%
1Y
-21.7%
Selvita
Market Cap: zł805.8m
Operates as a contract research organization worldwide.
SLV
zł43.90
7D
1.6%
1Y
-11.9%
Ryvu Therapeutics
Market Cap: zł635.8m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł27.50
7D
1.5%
1Y
-29.0%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł442.3m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł80.00
7D
11.1%
1Y
83.1%
Bioceltix
Market Cap: zł394.9m
Engages in the development of stem cell-based biopharmaceuticals for veterinary use.
BCX
zł80.20
7D
3.4%
1Y
-6.9%
BIOTON
Market Cap: zł343.5m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł4.00
7D
3.6%
1Y
24.0%
Synthaverse
Market Cap: zł285.2m
A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.
SVE
zł4.03
7D
10.4%
1Y
-10.4%
Molecure
Market Cap: zł143.2m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł6.95
7D
5.3%
1Y
-26.0%
Mabion
Market Cap: zł127.5m
A biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.
MAB
zł7.89
7D
13.0%
1Y
-20.3%
Poltreg
Market Cap: zł118.9m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł25.50
7D
4.1%
1Y
-40.1%
NanoGroup
Market Cap: zł87.8m
Operates as a biotechnology company in Poland.
NNG
zł2.73
7D
3.0%
1Y
-23.5%
HyEnergy
Market Cap: zł77.9m
Provides genetic diagnostic solutions in Poland.
HEN
zł2.32
7D
0%
1Y
-34.6%
Read-Gene
Market Cap: zł64.4m
Engages in the detection, prevention, and treatment of various types of cancer.
RDG
zł5.46
7D
0%
1Y
7.9%
Urteste
Market Cap: zł64.1m
Engages in the research and development of diagnostic tests for cancers.
URT
zł45.50
7D
16.7%
1Y
-52.6%
Genomtec
Market Cap: zł55.7m
Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.
GMT
zł3.70
7D
-2.6%
1Y
-53.0%
Biogened
Market Cap: zł53.1m
Produces and sells cosmetics and toiletries in Poland.
BGD
zł21.60
7D
0%
1Y
-7.7%
Genomed Spólka Akcyjna
Market Cap: zł39.9m
Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.
GEN
zł30.20
7D
24.8%
1Y
10.2%
Pure Biologics
Market Cap: zł35.0m
A biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases.
PUR
zł4.29
7D
20.3%
1Y
-74.4%
Medicofarma Biotech
Market Cap: zł25.5m
Engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.
MDB
zł0.38
7D
-6.0%
1Y
-8.1%
Stem Cells Spin
Market Cap: zł17.3m
Operates as a biotechnology company in Poland.
SCS
zł0.42
7D
3.0%
1Y
91.7%
genXone
Market Cap: zł14.2m
Operates in the biotechnology industry in Poland and internationally.
GX1
zł4.31
7D
8.0%
1Y
-29.3%
Green Zebras Spolka Akcyjna
Market Cap: zł12.2m
Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.
GRZ
zł9.20
7D
-6.1%
1Y
-31.3%
Cannabis Poland
Market Cap: zł10.8m
Operates in the medical cannabis industry in Poland.
CBD
zł0.22
7D
10.3%
1Y
-38.2%
Labocanna
Market Cap: zł4.9m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.23
7D
23.5%
1Y
-32.4%
Vinci Gen
Market Cap: zł3.2m
Engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.
VGN
zł0.30
7D
-2.6%
1Y
-33.5%